WO1997004812A3 - Verwendung von mri-kontrastmitteln zur ventilations-bildgebung der lunge - Google Patents

Verwendung von mri-kontrastmitteln zur ventilations-bildgebung der lunge Download PDF

Info

Publication number
WO1997004812A3
WO1997004812A3 PCT/DE1996/001435 DE9601435W WO9704812A3 WO 1997004812 A3 WO1997004812 A3 WO 1997004812A3 DE 9601435 W DE9601435 W DE 9601435W WO 9704812 A3 WO9704812 A3 WO 9704812A3
Authority
WO
WIPO (PCT)
Prior art keywords
imagery
agents
pulmonary ventilation
ventilation
pulmonary
Prior art date
Application number
PCT/DE1996/001435
Other languages
English (en)
French (fr)
Other versions
WO1997004812A2 (de
Inventor
Andreas Muehler
Thomas Frenzel
Bernd Misselwitz
Hanns-Joachim Weinmann
Andreas Sachse
Celal Albayrak
Original Assignee
Andreas Muehler
Thomas Frenzel
Bernd Misselwitz
Hanns-Joachim Weinmann
Andreas Sachse
Celal Albayrak
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andreas Muehler, Thomas Frenzel, Bernd Misselwitz, Hanns-Joachim Weinmann, Andreas Sachse, Celal Albayrak, Schering Ag filed Critical Andreas Muehler
Priority to AU68694/96A priority Critical patent/AU6869496A/en
Publication of WO1997004812A2 publication Critical patent/WO1997004812A2/de
Publication of WO1997004812A3 publication Critical patent/WO1997004812A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests

Abstract

Die Erfindung betrifft die Verwendung von Kontrastmittelformulierungen zur Ventilationsdiagnostik der Lungenalveolen.
PCT/DE1996/001435 1995-08-01 1996-07-25 Verwendung von mri-kontrastmitteln zur ventilations-bildgebung der lunge WO1997004812A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU68694/96A AU6869496A (en) 1995-08-01 1996-07-25 Pulmonary ventilation imagery agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19529921.3 1995-08-01
DE1995129921 DE19529921C2 (de) 1995-08-01 1995-08-01 Verwendung von MRT-Kontrastmitteln zur Ventilations-Bildgebung der Lunge

Publications (2)

Publication Number Publication Date
WO1997004812A2 WO1997004812A2 (de) 1997-02-13
WO1997004812A3 true WO1997004812A3 (de) 1997-09-18

Family

ID=7769484

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/001435 WO1997004812A2 (de) 1995-08-01 1996-07-25 Verwendung von mri-kontrastmitteln zur ventilations-bildgebung der lunge

Country Status (3)

Country Link
AU (1) AU6869496A (de)
DE (1) DE19529921C2 (de)
WO (1) WO1997004812A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004006048B4 (de) * 2004-02-02 2009-11-26 Axxonis Pharma Ag Intravenös zu verabreichende Injektions-oder Infusionslösung enthaltend ein Kombinationsarzneimittel zur Verwendung als konstrastverstärkendes Mittel in der MR Angiographie

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387154A1 (de) * 1989-03-08 1990-09-12 Pierre Fabre Medicament Aerosol-Zusammensetzung für Bilderzeugungs-Diagnostik und Therapie von Krebs- und Infektionsherden
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US5350571A (en) * 1988-04-29 1994-09-27 Hemagen/Pfc Emulsions of highly fluorinated organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350571A (en) * 1988-04-29 1994-09-27 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
EP0387154A1 (de) * 1989-03-08 1990-09-12 Pierre Fabre Medicament Aerosol-Zusammensetzung für Bilderzeugungs-Diagnostik und Therapie von Krebs- und Infektionsherden
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BERTHEZENE Y ET AL: "Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion.", RADIOLOGY, JUN 1992, VOL. 183, NO. 3, PAGE(S) 667-72, XP000674417 *
BERTHEZENE Y ET AL: "Safety aspects and pharmacokinetics of inhaled aerosolized gadolinium.", J MAGN RESON IMAGING, JAN-FEB 1993, VOL. 3, NO. 1, PAGE(S) 125-30, UNITED STATES, XP000674418 *
HOSOYA K.-I. ET AL: "Evaluation of enhancers to increase nasal absorption using Ussing chamber technique", BIOL. PHARM. BULL., 1994, VOL. 17, NO. 2, PAGE(S) 316-322, XP000676693 *
MONTGOMERY AB ET AL: "Aerosolized gadolinium -DTPA enhances the magnetic resonance signal of extravascular lung water.", INVEST RADIOL, MAY 1987, VOL. 22, NO. 5, PAGE(S) 377-81, XP000674359 *

Also Published As

Publication number Publication date
AU6869496A (en) 1997-02-26
WO1997004812A2 (de) 1997-02-13
DE19529921C2 (de) 1997-09-25
DE19529921A1 (de) 1997-02-06

Similar Documents

Publication Publication Date Title
AU3731997A (en) Emulsion formulations for hydrophilic active agents
EP0823993A3 (de) PH-empfindliche Mikrokapseln.
CA2225813A1 (en) Antiparasitic marcfortines and paraherquamides
AU1818695A (en) Gas-containing microcapsules useful as contrast agents for diagnostic imaging
AU2276495A (en) Contrast agents for diagnostic imaging
AU5223599A (en) Creating task-dependent three-dimensional images
AU1433299A (en) Disinfecting agent
ZA979812B (en) Cyanoacrylate compositions comprising an antimicrobial agent.
AU3849197A (en) Tramadol multiple unit formulations
AU2000254678A1 (en) 3d autonomous integrity monitored extrapolation navigation
ZA955642B (en) Lyophilized imaging agent formulation
CA2304568A1 (en) Olanzapine pamoate formulations
AU9601698A (en) Prepolymer compositions comprising an antimicrobial agent
AU1966095A (en) Dairy case confection
AU1121799A (en) Emulsion composition monitor
ZA977668B (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations.
ZA976891B (en) Diagnostic imaging contrast agent.
AU4418096A (en) Diagnosis of pancreatitis
WO1997004812A3 (de) Verwendung von mri-kontrastmitteln zur ventilations-bildgebung der lunge
ZA9997B (en) Stabilization of Lipid: DNA Formulations during Nebulization.
AU6977198A (en) Human phosphatidic acid phosphatase
AU1296199A (en) Prepolymer compositions comprising an antimicrobial agent
AU8269998A (en) Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
AU1352899A (en) Universal shoes
ZA976889B (en) Diagnostic imaging contrast agent.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BG BR BY CA CN CZ EE FI GE HU IL IS JP KP KR KZ LT LV MX NO NZ PL RO RU SG SI SK TJ TM TR UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA